Galapagos announces phase IIa results with GLPG1690 in IPF patients August 11, 2017 CenterWatch Staff
Gilead announces FDA priority review designation for fixed-dose treatment of HIV August 11, 2017 CenterWatch Staff
Ocugen receives FDA Orphan designation for ocular graft versus host disease August 10, 2017 CenterWatch Staff
First FDA-approved treatment for ALS in 22 years now available in U.S. August 9, 2017 CenterWatch Staff
FDA approves Idhifa for relapsed or refractory acute myeloid leukemia August 2, 2017 CenterWatch Staff